Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives $19.00 Average PT from Brokerages

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has been given an average rating of “Buy” by the six research firms that are covering the company, Marketbeat.com reports. Four investment analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $13.63.

BIOX has been the topic of a number of recent analyst reports. Oppenheimer cut their price target on Bioceres Crop Solutions from $17.00 to $16.00 and set an “outperform” rating on the stock in a report on Wednesday, September 11th. Roth Mkm cut their price target on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, September 11th. Lake Street Capital dropped their target price on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, September 11th. Canaccord Genuity Group raised Bioceres Crop Solutions to a “strong-buy” rating in a report on Friday, July 19th. Finally, Canaccord Genuity Group dropped their target price on Bioceres Crop Solutions from $17.00 to $12.50 and set a “buy” rating on the stock in a report on Wednesday, September 11th.

Bioceres Crop Solutions Stock Performance

BIOX opened at $8.48 on Wednesday. The business’s 50 day moving average is $10.34 and its 200-day moving average is $11.33. The stock has a market cap of $532.52 million, a PE ratio of 848.00 and a beta of 0.49. The company has a current ratio of 1.28, a quick ratio of 0.83 and a debt-to-equity ratio of 0.35. Bioceres Crop Solutions has a twelve month low of $8.16 and a twelve month high of $14.05.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings results on Monday, September 9th. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.23). The business had revenue of $124.30 million for the quarter, compared to the consensus estimate of $126.75 million. Bioceres Crop Solutions had a net margin of 0.68% and a return on equity of 0.93%. During the same period last year, the firm posted ($0.06) EPS. On average, analysts predict that Bioceres Crop Solutions will post 0.81 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Activest Wealth Management acquired a new position in Bioceres Crop Solutions in the first quarter worth approximately $30,000. Cape Investment Advisory Inc. acquired a new position in Bioceres Crop Solutions in the fourth quarter worth approximately $33,000. Oppenheimer & Co. Inc. acquired a new position in Bioceres Crop Solutions in the first quarter worth approximately $139,000. Lazard Asset Management LLC acquired a new position in Bioceres Crop Solutions in the first quarter worth approximately $212,000. Finally, Ping Capital Management Inc. acquired a new position in Bioceres Crop Solutions in the second quarter worth approximately $448,000. Institutional investors and hedge funds own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.